Image 2_Targeting the PI3K/AKT/mTOR pathway in lung cancer: mechanisms and therapeutic targeting.tif

<p>Owing to its high mortality rate, lung cancer (LC) remains the most common cancer worldwide, with the highest malignancy diagnosis rate. The phosphatidylinositol-3-kinase (PI3K)/protein kinase B (AKT)/mammalian target of rapamycin (mTOR) signaling (PAM) pathway is a critical intracellular p...

Full description

Saved in:

Bibliographic Details
Main Author:	Min Qiang (8120708) (author)
Other Authors:	Zhe Chen (196097) (author), Hongyang Liu (303058) (author), Junxue Dong (14584793) (author), Kejian Gong (18766888) (author), Xinjun Zhang (621709) (author), Peng Huo (1824898) (author), Jingjun Zhu (10853525) (author), Yifeng Shao (5730938) (author), Jinazun Ma (20743565) (author), Bowei Zhang (334192) (author), Wei Liu (20030) (author), Mingbo Tang (11580966) (author)
Published:	2025
Subjects:	Pharmacology PI3K/Akt/mTOR pathway lung cancer PI3K inhibitors Akt inhibitors mTOR inhibitors natural products combined therapy
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!

Image 2_Targeting the PI3K/AKT/mTOR pathway in lung cancer: mechanisms and therapeutic targeting.tif

Similar Items